Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis
The DOI matches its Crossref record.
Abstract
Pemoline (Cylert) is a central nervous system stimulant first introduced into clinical trials in the 1970s. Currently, it is most commonly used to treat children with attention deficit disorder (ADD).1,2 There have been scattered reports of hepatotoxicity with pemoline usually involving transient elevation of liver chemistries.3-6 Overt liver failure has been rarely reported.7-10 During the last 3 years we encountered four cases of marked liver dysfunction in children on pemoline. Two of these progressed to fulminant hepatic failure requiring liver transplantation. In those cases where autoantibodies were measured, there was evidence for autoimmune activation (see Tables1 and 2). View this table: Table 1. Pemoline Treatment and Autoimmune Findings View this table: Table 2. Presentation and Outcome ### Case 1 This patient was an adopted 14-year-old girl with ADD unresponsive to methylphenidate. Pemoline, 37.5 mg per day, was instituted with some improvement in school performance. Liver chemistries were not routinely monitored. Six months later, jaundice and fatigue developed. Physical examination was notable for jaundice and no organomegaly. Liver transaminases were in the 1000 IU/L range with a total bilirubin of 8 mg/dL with a direct fraction of 6 mg/dL. The serum albumin level was normal but the prothrombin time was elevated to 17 seconds (normal <13 seconds) and was unresponsive to subcutaneous vitamin K. Pemoline was immediately discontinued. Serologic evaluation for Hepatitis A,B,C as well as cytomegalovirus and Epstein Barr virus (EBV) gave negative results. Serum ceruloplasmin and α-1-antitrypsin levels and phenotype were normal. Abdominal ultrasound showed nonspecific heterogeneity of the liver parenchyma. Antinuclear antibody (ANA) measured positive 1:80 with a speckled pattern and antiparietal cell antibodies were isolated. Antismooth muscle, antimitochondrial, and liver-kidney microsomal antibodies were all negative. Over the next 3 weeks, the patient developed worsening jaundice and coagulopathy. She developed grade IV hepatic encephalopathy and underwent orthotopic liver transplantation. The explanted liver was shrunken …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
Lawlor, P. G. (2002) · Cancer · doi:10.1002/cncr.10389 · Cited by 116
Metadata
- Authors
- Rosh, J. R., Dellert, S. F., Narkewicz, M., Birnbaum, A., & Whitington, G.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1998-05-01
- Volume
- 101
- Issue
- 5
- Pages
- 921-923
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2100220506
- Cited by
- 40
- References
- 0
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis. https://app.cochat.ai/papers/10.1542/peds.101.5.921
- The paper
- Rosh, J. R., Dellert, S. F., Narkewicz, M., Birnbaum, A., & Whitington, G. (1998). Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis. Pediatrics. https://doi.org/10.1542/peds.101.5.921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.